Tag: Tiziana Life Sciences PLC

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Tiziana Life Sciences PLC

Tiziana Life Sciences Interview to Air on Bloomberg Television US on the RedChip Money Report

Added to Collection on: 2021-05-07 06:00:00

Tags for this article:

Medical specialties
Clinical medicine
Immunology
Medicine
Foralumab
Interleukin-6 receptor
Forward-looking statement
Monoclonal antibody
Antibody
Tiziana Life Sciences PLC
redchip companies inc

Click the tags to see associated articles and topics

View Article Details
Tiziana Life Sciences confident of advancing drug development pipeline

Added to Collection on: 2021-05-18 13:07:30

Tags for this article:

Organic compounds
Chemical compounds
Medical specialties
Chloroarenes
Pyridines
Ureas
Hepatology
Hepatocellular carcinoma
Regorafenib
Sorafenib
Monoclonal antibody
Drug development
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details
Tiziana Reports Data Indicating Significant Immunomodulation effects on Immune and ...

Added to Collection on: 2021-05-26 06:00:00

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Interleukins
Cancer treatments
Cancer immunotherapy
Immunotherapy
Virotherapy
Cytokine release syndrome
Interleukin 6
Cytokine
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details
TLSA: Nasally-administered Foralumab Trial in SPMS Patient

Added to Collection on: 2021-05-27 15:11:15

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Multiple sclerosis
Autoimmune diseases
Cytokine release syndrome
Immunotherapy
Crohn's disease
Multiple sclerosis drug pipeline
Multiple sclerosis biomarkers
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details
Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a

Added to Collection on: 2021-09-07 06:00:00

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Monoclonal antibodies
Foralumab
Anti-CD3 monoclonal antibody
Crohn's disease
Immunotherapy
Autoimmune disease
Cytokine release syndrome
Interleukin-6 receptor
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details
Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021 - TylerPaper.com

Added to Collection on: 2021-09-24 17:15:00

Tags for this article:

Monoclonal antibodies
Medical specialties
Clinical medicine
Medicine
Immunology
Foralumab
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details
Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021 | News ...

Added to Collection on: 2021-09-24 17:15:00

Tags for this article:

Monoclonal antibodies
Medical specialties
Clinical medicine
Medicine
Immunology
Foralumab
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D ...

Added to Collection on: 2021-10-07 12:22:30

Tags for this article:

Life Sciences
Companies
Biotechnology companies
Economy of New York City
NASDAQ
Amgen
MorphoSys
Vertex Pharmaceuticals
Pluristem Therapeutics
PTC Therapeutics
ensysce biosciences, inc.
DURECT Corporation
Indaptus Therapeutics Inc.
Aziyo Biologics Inc.
eiger biopharmaceuticals inc
Minerva Neurosciences Inc
Aytu BioPharma Inc.
Orphazyme A/S
ROCKWELL MEDICAL , INC
Glaukos Corporation
Heron Therapeutics Inc
Longeveron Inc.
HCW Biologics Inc.
Catalyst Pharmaceuticals Inc
Hoth Therapeutics Inc.
DICE Therapeutics, Inc.
TELIGENT , INC
Aptinyx Inc.
Nuwellis Inc.
Adverum Biotechnologies Inc.
BiondVax Pharmaceuticals Ltd.
Spruce Biosciences Inc.
Mesoblast Limited
Chemomab Therapeutics, Ltd.
Kiniksa Pharmaceuticals Ltd
trevi therapeutics, inc.
Black Diamond Therapeutics, Inc.
Avenue Therapeutics Inc.
China SXT Pharmaceuticals Inc.
Amgen Inc.
POINT Biopharma Global Inc.
TCR2 Therapeutics Inc.
Pluristem Therapeutics Inc.
Forte Biosciences Inc.
Vertex Pharmaceuticals Incorporated
Oncorus Inc.
Year Moderna, Inc.
Acutus Medical Inc.
Neovasc Inc.
Spectrum Pharmaceuticals Inc.
Oyster Point Pharma Inc.
Incyte Corporation
Moleculin Biotech Inc.
Nautilus Biotechnology Inc.
Caladrius Biosciences Inc.
MORPHOSYS AG
Inhibikase Therapeutics Inc.
Galecto Inc.
MaxCyte Inc.
Immunic Inc
Kiromic BioPharma Inc.
Cellectis SA
Gamida Cell Ltd
BioSig Technologies Inc.
LumiraDx Limited
NRx Pharmaceuticals, Inc.
Stoke Therapeutics Inc
histogen inc
Calliditas Therapeutics AB
PTC Therapeutics Inc.
Solid Biosciences Inc.
Aravive Inc
Titan Pharmaceuticals Inc.
Roivant Sciences Ltd.
Liminal BioSciences Inc.
Akoya Biosciences Inc.
Kaleido Biosciences Inc.
Applied Genetic Technologies Corporation
Moderna
Assertio Holdings Inc.
Talis Biomedical Corporation
Sangamo Therapeutics Inc.
Lixte Biotechnology Holdings Inc.
Petros Pharmaceuticals Inc.
KALA PHARMACEUTICALS, INC
XBiotech Inc.
Orchard Therapeutics plc
Legend Biotech Corporation
Galapagos NV
Angion Biomedica Corp
Applied Dna Sciences Inc.
Esperion Therapeutics Inc.
Imara Inc.
Enanta Pharmaceuticals Inc.
Harpoon Therapeutics Inc.
Graphite Bio Inc.
Tiziana Life Sciences PLC
BioVie Inc
Applied Molecular Transport Inc.
Viveve Medical Inc.
Immuron Limited
Protara Therapeutics Inc.
4d molecular therapeutics
HOOKIPA Pharma Inc.
Pasithea Therapeutics Corp.
CASI PHARMACEUTICALS , INC
InMed Pharmaceuticals Inc.
Gain Therapeutics Inc.
NeuroBo Pharmaceuticals Inc.
Opiant Pharmaceuticals Inc
Lipocine Inc

Click the tags to see associated articles and topics

View Article Details
Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of ...

Added to Collection on: 2021-10-19 20:13:11

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Monoclonal antibodies
Foralumab
Immunology
Tiziana
Crohn's disease
Interleukin-6 receptor
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details
Tiziana Life Sciences PLC (NASDAQ:TLSA) Short Interest Up 61.9% in January - ETF Daily News

Added to Collection on: 2022-02-02 10:53:58

Tags for this article:

Finance
Financial markets
Financial economics
Stock market
Financial regulation
Short
Stock
Geode Capital Management
Tiziana Life Sciences PLC

Click the tags to see associated articles and topics

View Article Details